Ruff Shamim
Insider CIK 1685986 · RETA Director · SRPT SVP, Regulatory Affairs & Qual
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 1,405 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 443 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 780 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 5,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 3,334 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 2,137 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 576 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 7,359 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-07-28 | 2023-08-01 | 1,250 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-07-28 | 2023-08-01 | 319 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-07-28 | 2023-08-01 | 6,666 | — | $0 | 3,334 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise | 2023-07-28 | 2023-08-01 | 1,250 | $92.20 | $115.3K | 8,609 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-07-28 | 2023-08-01 | 8,235 | $164.53 | $1.35M | 7,359 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise | 2023-07-28 | 2023-08-01 | 319 | $92.20 | $29.4K | 15,594 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise | 2023-07-28 | 2023-08-01 | 6,666 | $92.20 | $614.6K | 15,275 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 576 | $73.68 | $42.4K | 576 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 2,137 | — | $0 | 2,137 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-06-07 | 2023-06-09 | 454 | $93.61 | $42.5K | 5,677 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-06-07 | 2023-06-09 | 1,682 | $93.61 | $157.5K | 7,359 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-03-10 | 2023-03-13 | 1,326 | — | $0 | 443 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-03-10 | 2023-03-13 | 4,215 | — | $0 | 1,405 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-03-10 | 2023-03-13 | 199 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise | 2023-03-10 | 2023-03-13 | 4,215 | $34.76 | $146.5K | 10,963 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-10 | 2023-03-13 | 5,740 | $83.73 | $480.6K | 5,223 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise | 2023-03-10 | 2023-03-13 | 199 | $27.32 | $5.4K | 5,422 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise | 2023-03-10 | 2023-03-13 | 1,326 | $34.76 | $46.1K | 6,748 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-09 | 1,769 | $24.02 | $42.5K | 1,769 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-09 | 5,620 | — | $0 | 5,620 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-06-08 | 2022-06-09 | 1,222 | $34.76 | $42.5K | 1,340 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-06-08 | 2022-06-09 | 3,883 | $34.76 | $135.0K | 5,223 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-01-03 | 2022-01-05 | 199 | $16.14 | $3.2K | 199 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-01-03 | 2022-01-05 | 118 | $27.32 | $3.2K | 118 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-06-10 | 2021-06-14 | 780 | $83.24 | $64.9K | 780 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-06-10 | 2021-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-04-15 | 2021-04-16 | 1,250 | — | $0 | 1,250 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-04-15 | 2021-04-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-04-15 | 2021-04-16 | 319 | $52.85 | $16.9K | 319 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-05-22 | 2018-05-24 | 4,432 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-05-22 | 2018-05-24 | 4,432 | — | $0 | 33,241 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-05-22 | 2018-05-24 | 1,305 | $89.22 | $116.4K | 31,936 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-03-15 | 2018-03-16 | 2,031 | — | $0 | 10,066 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2018-03-15 | 2018-03-16 | 469 | — | $0 | 6,134 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-03-15 | 2018-03-16 | 656 | $81.22 | $53.3K | 28,809 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2018-03-15 | 2018-03-16 | 80 | $81.22 | $6.5K | 27,434 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-03-15 | 2018-03-16 | 2,031 | $26.24 | $53.3K | 29,465 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2018-03-15 | 2018-03-16 | 469 | $13.90 | $6.5K | 27,514 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2018-03-05 | 2018-03-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2017-11-06 | 2017-11-08 | 10,000 | $14.76 | $147.6K | 31,144 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2017-11-06 | 2017-11-08 | 10,000 | $14.76 | $147.6K | 37,045 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2017-11-06 | 2017-11-08 | 10,000 | $55.00 | $550.0K | 27,045 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2017-10-03 | 2017-10-05 | 11,500 | $14.76 | $169.7K | 41,144 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2017-10-03 | 2017-10-05 | 11,500 | $14.76 | $169.7K | 38,545 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2017-10-03 | 2017-10-05 | 11,500 | $50.00 | $575.0K | 27,045 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2017-08-03 | 2017-08-07 | 8,865 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2017-08-03 | 2017-08-07 | 2,882 | $37.88 | $109.2K | 27,045 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2017-08-03 | 2017-08-07 | 8,865 | — | $0 | 29,927 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2017-07-21 | 2017-07-21 | 4,388 | $13.90 | $61.0K | 5,098 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2017-07-21 | 2017-07-21 | 1,500 | $14.76 | $22.1K | 52,644 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2017-07-21 | 2017-07-21 | 4,388 | $44.00 | $193.1K | 21,062 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2017-07-21 | 2017-07-21 | 1,500 | $44.00 | $66.0K | 21,062 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2017-07-21 | 2017-07-21 | 1,500 | $14.76 | $22.1K | 22,562 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2017-07-21 | 2017-07-21 | 4,388 | $13.90 | $61.0K | 25,450 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2017-07-20 | 2017-07-21 | 6,250 | $13.71 | $85.7K | 17,708 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2017-07-20 | 2017-07-21 | 6,250 | $42.00 | $262.5K | 21,062 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2017-07-20 | 2017-07-21 | 6,250 | $13.71 | $85.7K | 27,312 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2017-03-19 | 2017-03-21 | 177 | $30.30 | $5.4K | 21,062 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2017-03-10 | 2017-03-14 | 4,189 | — | $0 | 4,189 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2017-03-10 | 2017-03-14 | 20,811 | — | $0 | 20,811 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2016-11-08 | 2016-11-10 | 1,000 | — | $0 | 12,097 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2016-11-08 | 2016-11-10 | 1,000 | $26.24 | $26.2K | 21,239 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2016-09-22 | 2016-09-30 | 7,311 | $13.90 | $101.6K | 8,486 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | S Sale | 2016-09-22 | 2016-09-30 | 7,311 | $60.00 | $438.7K | 20,239 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2016-09-22 | 2016-09-30 | 7,311 | $13.90 | $101.6K | 27,550 | SEC↗ |